laboratory tests for respiratory system disease
TRANSCRIPT
-
7/29/2019 Laboratory Tests for Respiratory System Disease
1/40
LABORATORY TESTS FOR
RESPIRATORY SYSTEMDISEASE
Kemas Yakub R, dr., SpPK
Dept. of Clinical PathologyMedical School University of Sriwijaya
-
7/29/2019 Laboratory Tests for Respiratory System Disease
2/40
dr. Kemas Yakub SpPK 2
Infection
Non-Infection
Tumor
-
7/29/2019 Laboratory Tests for Respiratory System Disease
3/40
dr. Kemas Yakub SpPK 3
INTRODUCTION
The laboratory examination has an important
role as a diagnostic tools
The accuracy of any laboratory result beginsat the beginning, with proper laboratoryspecimen collection
The foundation of reliable and validlaboratory results starts with the specimencollection and the way in which it wasobtained
-
7/29/2019 Laboratory Tests for Respiratory System Disease
4/40
dr. Kemas Yakub SpPK 4
The nature of the test dictates themanner in which the specimen iscollected
Some specimen collections are
complicated and require speciallytrained technical personal
Most specimen collections are not
complicated
-
7/29/2019 Laboratory Tests for Respiratory System Disease
5/40
dr. Kemas Yakub SpPK 5
Proper collection depends on givingclear and concise instruction to thepatient
Patient instruction is the responsibilityof clinical laboratorians
-
7/29/2019 Laboratory Tests for Respiratory System Disease
6/40
dr. Kemas Yakub SpPK 6
THE TEST REQUEST
The specimen testing initiated by physicianwho request the certain test be performed on
a patient
The request form usually contains all relevantinformation regarding the patient identity
-
7/29/2019 Laboratory Tests for Respiratory System Disease
7/40
dr. Kemas Yakub SpPK 7
DOCUMENTATION
The variety of biologic specimens, themultitude of analytes and the variousmethods of specimen and transport all
provide opportunities where inaccuracies anderrors may be introduced into the testprocedure
The laboratory requires that documentationof specimen collection procedure areavailable.
-
7/29/2019 Laboratory Tests for Respiratory System Disease
8/40
dr. Kemas Yakub SpPK 8
PROCEDURE MANUAL
Name of the test
Specimen type and quantity
Method of collection
Patient preparation Labeling information
Special handling
Criteria of rejection Stability and time constrains
-
7/29/2019 Laboratory Tests for Respiratory System Disease
9/40
dr. Kemas Yakub SpPK 9
TRANSPORTATION
For transportation all special requirementsnecessary to preserve the specimen must befollowed
Every specimens needs the proper condition,e.g refrigerated, iced, preservatives
Some specimens collections involves test thatare very personal and highly confidential
-
7/29/2019 Laboratory Tests for Respiratory System Disease
10/40
dr. Kemas Yakub SpPK 10
Specimens from Upper Respiratory Tract
Nose swab: useful to identify carriers ofMethycilinresistant Staphylococcus aureus (MRSA),SARS
(severe acute respiratory syndrome).
-
7/29/2019 Laboratory Tests for Respiratory System Disease
11/40
dr. Kemas Yakub SpPK 11
Use tongue depressor
to prevent contact
with tongue or buccal
mucosa
-
7/29/2019 Laboratory Tests for Respiratory System Disease
12/40
dr. Kemas Yakub SpPK 12
NASOPHARYNX
-
7/29/2019 Laboratory Tests for Respiratory System Disease
13/40
dr. Kemas Yakub SpPK 13
SPUTUM SPECIMEN
Sputum must be deliberately coughed upfrom the lungs and lower bronchial tree
The patient must be gargle prior tocollection to reduce the number of normalflora
-
7/29/2019 Laboratory Tests for Respiratory System Disease
14/40
dr. Kemas Yakub SpPK 14
Many patients with Lower Tract Infection (LRTI) cough up
purulent sputum which may be cultured & examined grossly
& microscopically.The most common infections :
acute & chronic bronchitis
lung abscess
pneumonia & bronchopmneumonia
pulmonary tuberculosis
Because the bacteriologic procedure for the diagnosis of
other LRTI & Pulmonary tuberculosis are different, thephysician must make it clear to the Lab. wether they wishes
examinations for :
pyogenic bacteria, tubercle bacteria or both types
-
7/29/2019 Laboratory Tests for Respiratory System Disease
15/40
dr. Kemas Yakub SpPK 15
Collection of sputum specimen :
Best time : first sputum which is cough up early morningFor TBC : 3 x from 2 visits: spot - morning - spot.
Patient must informed how to cough to yield a good sputum
Collect in a sterile wide-mouthed container, tight-fitting cover,
sentto the Lab. without delay & not allowed 1 hour at room
temperature
before being processed in the lab.
Sputum to be examined : mucous with air bubbles containing
solid
or purulent particles, saliva is not acceptable.
-
7/29/2019 Laboratory Tests for Respiratory System Disease
16/40
dr. Kemas Yakub SpPK 16
-
7/29/2019 Laboratory Tests for Respiratory System Disease
17/40
dr. Kemas Yakub SpPK 17
A. Saliva
B. Good quality sputum: mucopurulent
A B
Use Sterile sputum container widemouth,
disposable,made of clear thin plastic, unbreakable, leakproof.
-
7/29/2019 Laboratory Tests for Respiratory System Disease
18/40
dr. Kemas Yakub SpPK 18
SPUTUM
Color in various conditions
Rusty Lobar pneumonia
Anchovy paste (dark brown) Amebic liver abscess rupture
into bronchus
Red currant jelly Klebsiella pneumoniae
Red (pigment, not blood) Serratia marcescens; rifampinoverdose
Black Bacteroides melaninogenicus
pneumonia; anthracosilicosis
Green (with WBCs, sweet odor) Pseudomonas infection
Milky Bronchioalveolar carcinoma
Yellow (without WBCs) Jaundice
-
7/29/2019 Laboratory Tests for Respiratory System Disease
19/40
dr. Kemas Yakub SpPK 19
-
7/29/2019 Laboratory Tests for Respiratory System Disease
20/40
dr. Kemas Yakub SpPK 20
Phlebotomy technique
Educational program of phlebotomy technique
Side ofVenipucture
(vp)
Scrubbed firmly but gently
directly over the side of vp
outward directioncircular strokes
3 times
Wiped alcohol padPlace over the septum
Inoculation time
-
7/29/2019 Laboratory Tests for Respiratory System Disease
21/40
dr. Kemas Yakub SpPK 21
-
7/29/2019 Laboratory Tests for Respiratory System Disease
22/40
dr. Kemas Yakub SpPK 22
BacT/ALERT for adult BacT/ALERT for kid
Blood Culture Boullion
-
7/29/2019 Laboratory Tests for Respiratory System Disease
23/40
dr. Kemas Yakub SpPK 23
PLEURAL EFFUSION
Normal Values Specific gravity 1.0101.026
Total protein
Albumin 0.3
4.1 gm/dL Globulin 5070%
Fibrinogen 3045%
pH 6.8
7.6
Transudate Exudate
-
7/29/2019 Laboratory Tests for Respiratory System Disease
24/40
dr. Kemas Yakub SpPK 24
BLOOD GAS ANALYSIS
1. pH : 7.40 + 0.05
2. pCO2 : 40 + 5 mmHg
3. pO2 : 80 - 100 mmHg
4. (HCO3-) : 24 + 2 mmol/L
5. TCO2 : 25,2 + 2 mmol/L
6. O2 - saturation : 95 - 98 %
7. Base, Negative (Base, deficient) : - 2,5
8. Base, Posotive (Base, Excess) : + 2,5
-
7/29/2019 Laboratory Tests for Respiratory System Disease
25/40
dr. Kemas Yakub SpPK 25
-
7/29/2019 Laboratory Tests for Respiratory System Disease
26/40
dr. Kemas Yakub SpPK 26
III. Compensatory Mechanisms
1. Buffer System :a. Carbonic acid Bicarbonate Buffer System :
CO2 + H20 H2CO3 H+ + HCO3-
b. Non Bicarbonate Buffer System :Hbuf H+ + Buf -
-
7/29/2019 Laboratory Tests for Respiratory System Disease
27/40
dr. Kemas Yakub SpPK 27
2. Lungs :
Compensate by altering the acid or respiratorycomponent during :
a. Hypoventilationb. Hypervertilation
3. Kidneys : Na+ - H+ ExchangeThe kidneys tend to correct for primaryabnormalities in the basic or metabolic (HCO3-)component.
-
7/29/2019 Laboratory Tests for Respiratory System Disease
28/40
dr. Kemas Yakub SpPK 28
Henderson - Hasselbalch Equation :
pH = 6.1 + Log [HCO3-] / [H2CO3] 24/1.2
6.1 + Log [HCO3-] / 0.03 x pCO2 24/1.2
6.1 + Log 24/1.2 = 6.1 + Log 20/1= 6.1 + 1.3 = 7.40
The mechanism for bicarbonate synthesis
reabsoption
( Na + - H+ exchange ) is illustrated in Fig.1,2,3
-
7/29/2019 Laboratory Tests for Respiratory System Disease
29/40
dr. Kemas Yakub SpPK 29
-
7/29/2019 Laboratory Tests for Respiratory System Disease
30/40
dr. Kemas Yakub SpPK 30
Steps in Laboratory Investigation of an Infected patient :
-
7/29/2019 Laboratory Tests for Respiratory System Disease
31/40
dr. Kemas Yakub SpPK 31
Steps in Laboratory Investigation of an Infected patient :
patient with infection
sampling transport,labelling
Storage Specimen, clinical data
Macroscopic evaluation,odour
Preliminary Report to PhysicianMicroscopy, interpretation
Culture, choice of medium,Toatmosph
Isolation of pure culture
Antibiogram Final Report to Physician
Identification, Interpretation
(contaminant, commensal/pathogen)
-
7/29/2019 Laboratory Tests for Respiratory System Disease
32/40
dr. Kemas Yakub SpPK 32
RESPIRATORY DISEASES
-
7/29/2019 Laboratory Tests for Respiratory System Disease
33/40
dr. Kemas Yakub SpPK 33
ABSCESS, LUNG
Sputum: marked increase; abundant, foul, purulent; maybe bloody; contains elastic fibers. Gram stain is diagnostic
Bacterial cultures (including tubercle bacilli)
Cytologic examination for malignant cells. Blood culture: may be positive in acute stage.
Increased WBC in acute stages (15,00030,000/cu mm)
Increased ESR
Normochromic normocytic anemia in chronic stage Albuminuria is frequent.
Findings of underlying disease
-
7/29/2019 Laboratory Tests for Respiratory System Disease
34/40
dr. Kemas Yakub SpPK 34
ASTHMA, BRONCHIAL
Eosinophilia may be present.
Sputum is white and mucoid without blood or pus (unlessinfection is present).
Eosinophils, crystals (Curschmann's spirals), and mucuscasts of bronchioles may be found.
When patient requires hospitalization, arterial bloodgases should be measured frequently to assess status.
Earliest change is decreased pCO2 with respiratory alkalosis with
normal pO2. Then pO2 decreases before pCO2 increases.Normal pCO2 suggests that the patient is tiring.
Acidemia and increased pCO2 suggest impending respiratory
failure.
Mixed metabolic and respiratory acidosis occurs.
-
7/29/2019 Laboratory Tests for Respiratory System Disease
35/40
dr. Kemas Yakub SpPK 35
BRONCHIECTASIS
WBC usually normal unless pneumonitis is present.
Mild to moderate normocytic normochromic anemia with
chronic severe infection
Sputum abundant and mucopurulent (often containsblood); sweetish smell
Sputum bacterial smears and cultures
Laboratory findings due to complications (pneumonia,
pulmonary hemorrhage, brain abscess, sepsis, cor
pulmonale)
-
7/29/2019 Laboratory Tests for Respiratory System Disease
36/40
dr. Kemas Yakub SpPK 36
BRONCHITIS
ACUTE Viruses cause most cases.
Mycoplasma pneumoniae, Chlamydia pneumoniae,
Bordetella pertussis, Legionella spp.
WBC and ESR may be increased.
CHRONIC
WBC and ESR normal or increased
Eosinophil count increased if there is allergic basis orcomponent
Smears and cultures of sputum and bronchoscopic
secretions
-
7/29/2019 Laboratory Tests for Respiratory System Disease
37/40
dr. Kemas Yakub SpPK 37
NASOPHARYNGITIS, ACUTE
Bacteria (e.g., Group A beta-hemolytic streptococci [1030%], H.influenzae, M. pneumoniae, etc.).
Virus (e.g., EBV, CMV, adenovirus, RSV, HSV, coxsackievirus)
Fungus, allergy, foreign body, trauma, neoplasm
Idiopathic (no cause is identified in ~50% of cases)
Microscopic Examination of Stained Nasal Smear
Large numbers of eosinophils suggest allergy. Does not correlatewith blood eosinophilia.
Eosinophils and neutrophils suggest chronic allergy withsuperimposed infection.
Large numbers of neutrophils suggest infection. Gram stain and culture of pharyngeal exudate may show significant
pathogen.
-
7/29/2019 Laboratory Tests for Respiratory System Disease
38/40
dr. Kemas Yakub SpPK 38
CROUP(EPIGLOTTITIS, LARYNGOTRACHEITIS)
Group B H. influenzae causes >90% of cases of
epiglottitis; other bacteria include beta-hemolytic
streptococci and pneumococci.
Cultures, smears,
Blood cultures should be taken at the same time
as throat cultures.
Neutrophilic leukocytosis is present..
Laryngotracheitis is usually viral (especially
parainfluenza) but rarely bacterial in origin.
-
7/29/2019 Laboratory Tests for Respiratory System Disease
39/40
dr. Kemas Yakub SpPK 39
Biochemical tumor markers
Serum CEA is increased in one-third to two-thirds of patients with all four types of lungcancer.
Principal uses are to monitor response totherapy and to correlate with staging.
Values 10 ng/mL correlate with higherincidence of extensive disease and extrathoracicmetastases.
-
7/29/2019 Laboratory Tests for Respiratory System Disease
40/40
d K Y k b S PK 40
Serum neuron-specific enolase may be
increased in
7987% with small cell cancer
10% with non
small cell cancer and nonmalignantlung diseases.
May be used to monitor disease progression;
falls in response to therapy and becomes normal
in complete remission but not useful for initialscreening or detecting early recurrence.